Aluminum

Tredegar

Tredegar released FY2026 Q1 earnings on May 8 (EST), actual revenue USD 186.53 M, actual EPS USD 0.1631

Tredegar released FY2025 Annual Earnings on March 11 During-Market EST, with actual revenue of USD 722.77 M and EPS of USD 0.9603

Tredegar released FY2025 Q4 earnings during market hours on March 11 (EST), actual revenue USD 185.68 M, actual EPS USD 0.4123

Tredegar to Release FY2025 Q4 Earnings Report on March 11 During-Market EST

Tredegar released FY2025 Q3 earnings on November 7 (EST), actual revenue USD 194.94 M, actual EPS USD 0.1989

Tredegar released FY2025 9 Months Earnings on November 7, 2025 (EST), with actual revenue of USD 538.58 M and EPS of USD 0.5406

Tredegar released FY2025 Semi-Annual Earnings on August 8 Pre-Market EST, actual revenue USD 343.63 M, actual EPS USD 0.341

Tredegar released FY2025 Q2 earnings on August 8 Pre-Market EST, actual revenue USD 179.12 M, actual EPS USD 0.0472

Tredegar to Release FY2025 Q2 Earnings on August 8, Pre-Market EST

Millennium Management LLC significantly reduced its holdings in Tridiga

Tridiga revises $125 million credit facility

Tredegar released FY2025 Q1 earnings on May 8 (EST), actual revenue USD 164.74 M, actual EPS USD 0.2918

Teridica Reports $10.1 Million Net Income in Q1 2025

Tridiga Maintains Holding Rating, Reports Profit Recovery in 2024

Tredegar released FY2024 Q4 earnings on March 12 (EST) with actual revenue of 154.05 M USD and EPS of -2.1199 USD

Tredegar released FY2024 earnings on March 12 (EST), actual revenue USD 598.37 M, actual EPS USD -1.8802

Tridiga Company Confirms $13.3 Million Impairment and Reports Q4 Net Income of $0.06 per Share

Tredegar released FY2024 9 Months Earnings on November 8 (EST), actual revenue USD 444.47 M, actual EPS USD 0.2353

Tredegar released FY2024 Q3 earnings on November 8 (EST), actual revenue USD 146.04 M, actual EPS USD -0.1161

Tredegar released FY2024 Q2 earnings on August 7 Pre-Market EST, actual revenue USD 154.46 M, actual EPS USD 0.2557

OPTIMI HEALTH CORP

HCW Biologics

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

Micware

GCL Global

Silexion Therapeutics

MetaVia

EMMIS ACQUISITION CORP. ORD USD0.0001 (S/R 12/09/2030)

Bristol-Myers Squibb Company

Tredegar Corp. (TG) shares have entered oversold territory with an RSI of 29.7, indicating potential buying opportunities as heavy selling may be exhausting. The stock traded as low as $7.10, with a 52-week range of $6.2501 to $10.53. Currently, shares are down about 3.8% for the day.

nasdaq

Nasdaq

TG Crosses Critical Technical Indicator

James T. Gottwald, a 10% owner of Tredegar, sold 30,221 shares for $258,896 on May 12, 2026. Following this transaction, he controls a total of 1,481,871 common shares, with 40,000 shares held directly and 1,441,871 indirectly. The SEC filing indicates a share price of $8.22, reflecting a change of +0.02 or +0.24%.

Fidelity

ISHRS S&P Glb Materials

Tredegar Insider Sold Shares Worth $258,896, According to a Recent SEC Filing

At Tredegar Corporation's Annual Meeting on May 8, 2026, shareholders represented 31,273,669 shares. The election of seven directors saw mixed support, with some nominees receiving strong backing while others faced opposition. An advisory vote on executive compensation passed but had over 12 million dissenting votes. Shareholders ratified KPMG LLP as the independent auditor for 2026. Spark's analysis rates TG stock as Neutral, citing improved financial health but tempered by overbought signals and moderate board transition impact. Tredegar operates under a standard U.S. public company framework with a market cap of $294.5M.

Tip Ranks

Spdr Material

VG Materials

Tredegar Shareholders Show Mixed Support at 2026 Meeting

Tredegar reported Q1 2026 net income of $5.1 million, or $0.15 per diluted share, with consolidated EBITDA from ongoing operations at $11.7 million, slightly up from $11.5 million in Q1 2025. The Aluminum Extrusions segment performed well, while High Performance Films faced softer demand. The company implemented price increases to mitigate tariff impacts and adjusted supply chains due to disruptions. Projected capital expenditures for 2026 are $20 million for Bonnell Aluminum and $2 million for High Performance Films.

TradingView

Tredegar reports Q1 2026 net income $5.1M, adjusted EPS $0.15; consolidated EBITDA from ongoing ops $11.7M

Tredegar(TG.US)

TG Crosses Critical Technical Indicator

Tredegar Insider Sold Shares Worth $258,896, According to a Recent SEC Filing

Tredegar Shareholders Show Mixed Support at 2026 Meeting

Tredegar reports Q1 2026 net income $5.1M, adjusted EPS $0.15; consolidated EBITDA from ongoing ops $11.7M

Tredegar | 8-K: FY2026 Q1 Revenue: USD 180.99 M

Tredegar Reports First Quarter 2026 Results | TG Stock News